Clin2
NCT06821685Possibly a fitRecruiting

Natural killer cell therapy for infertility and pregnancy problems

Abortion, HabitualInfertility UnexplainedEmbryo ImplantationPre-Eclampsia

Part of Women’s health & pregnancy clinical trials.

This study tests a treatment using your own immune cells (natural killer cells) to improve pregnancy chances. It's for women with infertility, repeated miscarriages, or other pregnancy complications linked to abnormal natural killer cell function.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
14 people
Ages
22 years to 40 years
Study type
Interventional

Who can take part

  • You have abnormal natural killer cell function in your uterus.
  • You have had at least 2 unexplained miscarriages, repeated IVF failure, or infertility for unknown reasons.
  • You have clear plans to get pregnant.
  • Your ovaries work normally or you have frozen embryos available.
  • You are between 18 and 30 in body mass index (BMI).
  • Your uterine lining is at least 7mm thick on ultrasound.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07230574Not yet recruiting· Phase 2
Autologous NK cell therapy for reproductive failure

This study tests whether a special type of your own natural killer (NK) cells—turned into 'decidual-like' cells—can help people who've had repeated pregnancy losses or failed IVF. The goal is to improve the chance of a successful pregnancy.

NCT06395844Recruiting· Phase 1/Phase 2
NK cell therapy for advanced ovarian cancer

This trial tests a new therapy that uses your own natural killer (NK) cells, modified to better fight cancer and injected directly into your abdomen. It's for people with advanced ovarian cancer who cannot have surgery or whose tumor cannot be fully removed.

Hefei, Anhui
NCT06367673Recruiting· Phase 1
NK cell therapy for relapsed or refractory AML

This trial tests a new natural killer (NK) cell therapy for adults with acute myeloid leukemia (AML) that has returned or not responded to treatment. The therapy targets two specific markers (CLL1 or CD33) on leukemia cells. It aims to see if these immune cells can safely fight the cancer.

Hangzhou, Zhejiang
NCT06321484Recruiting· Phase 1
NK cell therapy for recurrent platinum-resistant ovarian cancer

This trial tests a new type of immune cell therapy (CIML NK cells) given directly into the abdomen for women with ovarian cancer that has come back and is now resistant to standard platinum chemotherapy. The goal is to see if these specially trained cells can fight the cancer safely.

Boston, Massachusetts
NCT07784777Not yet recruiting· Phase 1
Natural killer cell infusion for advanced solid tumors

This trial tests an investigational natural killer (NK) cell therapy for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if these immune cells can shrink tumors and are safe.

NCT05421364Recruiting
Boosting your own immune cells to improve the uterine lining

This study gives a small amount of your own immune cells into the uterus to change the immune environment in the uterine lining. It aims to improve how the uterine lining supports implantation, especially for people trying to conceive with embryo transfer of normal (euploid) embryos.

Sofia, Sofia

Hear when a new Infertility Unexplained trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.